Jupiter Life Line Hospitals Limited Stock Price Today (NSE: JLHL)
Fundamental Score
Jupiter Life Line Hospitals Limited Share Price Live NSE/BSE & Institutional Fundamental Analysis
Jupiter Life Line Hospitals Limited share price today is ₹1282.00, up +0.00% on NSE/BSE as of 18 March 2026. Jupiter Life Line Hospitals Limited (JLHL) is a Mid-cap company in the Hospital sector with a market capitalisation of ₹9.68K (Cr). The 52-week high for JLHL share price is ₹N/A and the 52-week low is ₹N/A. At a P/E ratio of 48.76x, JLHL is currently trading below its industry average P/E of 52.84x. The company has a Return on Equity (ROE) of 14.95% and a debt-to-equity ratio of 0.28.
Jupiter Life Line Hospitals Limited Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Jupiter Life Line Hospitals Limited Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Jupiter Life Line Hospitals Share Price: A Conservative Value Investor's Perspective
The healthcare sector is undergoing significant transformation, driven by an aging population and increasing demand for specialized medical services. This analysis examines the Jupiter Life Line Hospitals share price (₹1251.800048828125) from a conservative value investing perspective, focusing on capital safety and long-term sustainability. This is part of an 80-parameter fundamental audit verified by Sweta Mishra.
Currently, Jupiter Life Line Hospitals has a Price-to-Earnings (PE) ratio of 48.76. This valuation is relatively high, suggesting that the market has significant expectations for future growth. As value investors, we would need to assess if this growth is reasonably achievable and if the current Jupiter Life Line Hospitals share price appropriately reflects the inherent risks.
A key metric for evaluating a company's efficiency is its Return on Capital Employed (ROCE). Jupiter Life Line Hospitals boasts a ROCE of 17.95%. A consistently high ROCE, like this, can act as a moat, indicating that the company possesses a competitive advantage. In the hospital business, this might stem from specialized services, strong brand reputation, or efficient cost management. However, it's crucial to examine if this ROCE is sustainable in the face of rising operating costs and regulatory changes.
When comparing Jupiter Life Line Hospitals Limited to its peers, such as
Nephro Care India Limited, we need to consider factors beyond just financial metrics. Management quality plays a vital role in the long-term success of a healthcare provider. Questions regarding executive compensation, strategic decision-making, and corporate governance become highly relevant. Evaluating the track record and experience of the management team at both Jupiter Life Line and Nephro Care India Limited is important in judging future success.Finally, a conservative analysis demands scrutinizing the company’s debt levels, cash flow generation, and future capital expenditure requirements. The high PE ratio suggests some premium. For value investors concerned about capital safety, careful evaluation is important before deciding if the current Jupiter Life Line Hospitals share price offers an adequate margin of safety.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Jupiter Life Line Hospitals Limited Fundamental Analysis & Valuation Benchmarking
Educational evaluation of JLHL across key market metrics for learning purposes.
Positive Indicators
10 factors identified
Excellent ROCE Performance (17.95%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Strong Operating Margins (21.60%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Strong Revenue Growth (17.48%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Consistent Growth Track Record (22.20% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Excellent EPS Growth (36.51% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential.
Strong Profit Growth Track Record (43.62% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Conservative Debt Levels (D/E: 0.28)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (11.82x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Strong Institutional Confidence (FII+DII: 26.03%)
Observation: Significant professional investor participation.
Analysis: High institutional holding often signals thorough due diligence.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
2 factors identified
Premium Valuation Risk (P/E: 48.76x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
Negative Free Cash Flow (₹-69.50 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Jupiter Life Line Hospitals Limited Financial Statements
Comprehensive financial data for Jupiter Life Line Hospitals Limited including income statement, balance sheet and cash flow
About JLHL (Jupiter Life Line Hospitals Limited)
Jupiter Life Line Hospitals Limited (JLHL) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Hospital sector with a current market capitalisation of ₹9.68K (Cr). Jupiter Life Line Hospitals Limited has delivered a Return on Equity (ROE) of 14.95% and a ROCE of 17.95%. The debt-to-equity ratio stands at 0.28, reflecting the company's capital structure. Investors tracking JLHL share price can monitor key metrics including P/E ratio, promoter holding of 40.91%, and quarterly earnings growth.
Company Details
Key Leadership
Corporate Events
JLHL Share Price: Frequently Asked Questions
What is the current share price of Jupiter Life Line Hospitals Limited (JLHL)?
As of 18 Mar 2026, 10:18 am IST, Jupiter Life Line Hospitals Limited share price is ₹1282.00. The JLHL stock has a market capitalisation of ₹9.68K (Cr) on NSE/BSE.
Is JLHL share price Overvalued or Undervalued?
JLHL share price is currently trading at a P/E ratio of 48.76x, compared to the industry average of 52.84x. Based on this relative valuation, the Jupiter Life Line Hospitals Limited stock appears to be Undervalued against its sector peers.
What is the 52-week high and low of JLHL share price?
The 52-week high of JLHL share price is ₹N/A and the 52-week low is ₹N/A.
What factors affect the Jupiter Life Line Hospitals Limited share price?
Key factors influencing JLHL share price include quarterly earnings growth (Sales Growth: 17.48%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Jupiter Life Line Hospitals Limited a good stock for long-term investment?
Jupiter Life Line Hospitals Limited shows a 5-year Profit Growth of 43.62% and an ROE of 14.95%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.28 before investing in JLHL shares.
How does Jupiter Life Line Hospitals Limited compare with its industry peers?
Jupiter Life Line Hospitals Limited competes with major peers in the Hospital. Investors should compare JLHL share price P/E of 48.76x and ROE of 14.95% against the industry averages to determine competitive standing.
What is the P/E ratio of JLHL and what does it mean?
JLHL share price has a P/E ratio of 48.76x compared to the industry average of 52.84x. Investors pay ₹49 for every ₹1 of annual earnings.
How is JLHL performing according to Bull Run's analysis?
JLHL has a Bull Run fundamental score of 62.9/100, indicating moderate strength with some areas for improvement. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does JLHL belong to?
JLHL operates in the Hospital industry. This classification helps understand the competitive landscape and sector-specific trends affecting Jupiter Life Line Hospitals Limited share price.
What is Return on Equity (ROE) and why is it important for JLHL?
JLHL has an ROE of 14.95%, which shows decent profitability but room for improvement. ROE measures how efficiently Jupiter Life Line Hospitals Limited generates profits from shareholders capital.
How is JLHL debt-to-equity ratio and what does it indicate?
JLHL has a debt-to-equity ratio of 0.28, which indicates conservative financing with low financial risk.
What is JLHL dividend yield and is it a good dividend stock?
JLHL offers a dividend yield of 0.07%, meaning you receive ₹0.07 annual dividend for every ₹100 invested in Jupiter Life Line Hospitals Limited shares.
How has JLHL share price grown over the past 5 years?
JLHL has achieved 5-year growth rates of: Sales Growth 22.20%, Profit Growth 43.62%, and EPS Growth 36.51%.
What is the promoter holding in JLHL and why does it matter?
Promoters hold 40.91% of JLHL shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Jupiter Life Line Hospitals Limited.
What is JLHL market capitalisation category?
JLHL has a market capitalisation of ₹9678 crores, placing it in the Mid-cap category.
How volatile is JLHL stock?
JLHL has a beta of N/A. A beta > 1 suggests the Jupiter Life Line Hospitals Limited stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is JLHL operating profit margin trend?
JLHL has a 5-year average Operating Profit Margin (OPM) of 21.60%, indicating the company's operational efficiency.
How is JLHL quarterly performance?
Recent quarterly performance shows Jupiter Life Line Hospitals Limited YoY Sales Growth of 17.48% and YoY Profit Growth of 11.04%.
What is the institutional holding pattern in JLHL?
JLHL has FII holding of 9.06% and DII holding of 16.97%. Significant institutional holding often suggests professional confidence in the Jupiter Life Line Hospitals Limited stock.